Inicio › Migraña › Connecticut
Ensayos clínicos de Migraña en Connecticut
10 estudios sobre Migraña buscan participantes en Connecticut.
Ciudades en Connecticut
Texto oficial del estudio (inglés)
Study of EVO756 in Adults With Migraine
- Hasbani Neurology, New Haven
- New England Institute for Neurology and Headache, Stamford
ReclutandoFase 2
Edades de 18 a 64 · Todos los sexos · Actualizado el 13 nov 2026 · NCT07616128A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Ki Health Partners, LLC, Stamford
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07816367A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Chase Medical Research, LLC, Waterbury
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07645924Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- CT Clinical Research, Cromwell
- Ki Health Partners, LLc, dba New England Institute for Clinical Research, Stamford
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 27 oct 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- CT Clinical Research, Cromwell
- Ki Health Partners, LLc, dba New England Institute for Clinical Research, Stamford
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 27 oct 2026 · NCT04649242A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Yale School of Medicine - The Scirex Clinical Research Unit, New Haven
- New England Institute for Clinical Research (NEICR) - Stamford, Stamford
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 14 oct 2026 · NCT05164172Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- New England Institute for Clinical Research, Stamford
- Chase Medical Research, Waterbury
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 9 oct 2026 · NCT07646613Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- New England Institute for Clinical Research /ID# 230635, Stamford
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 14 sept 2026 · NCT05125302Mechanistic Studies of Psilocybin in Headache Disorders
- VA Connecticut Healthcare System, West Haven
ReclutandoFase 1 tempranaSe aceptan voluntarios sanos
Edades de 21 a 70 · Todos los sexos · Actualizado el 13 jul 2026 · NCT06464367External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
- https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceL, Darien
ReclutandoEstudio observacional
Edades de 18 a 44 · Mujeres · Actualizado el 15 abr 2026 · NCT06788977De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.